radnet inc. - RDNT
RDNT
Close Chg Chg %
82.16 -0.86 -1.05%
Closed Market
81.30
-0.86 (1.05%)
Volume: 315.47K
Last Updated:
Nov 21, 2024, 4:00 PM EDT
Company Overview: radnet inc. - RDNT
RDNT Key Data
| Open $82.80 | Day Range 81.15 - 82.95 |
| 52 Week Range 31.55 - 93.65 | Market Cap $6.08B |
| Shares Outstanding 74.03M | Public Float 64.75M |
| Beta 1.75 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.06 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 567.48K |
RDNT Performance
| 1 Week | 3.24% | ||
| 1 Month | 23.79% | ||
| 3 Months | 26.40% | ||
| 1 Year | 153.89% | ||
| 5 Years | 346.28% |
RDNT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
6
Full Ratings ➔
About radnet inc. - RDNT
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The firm offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. RadNet was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.
RDNT At a Glance
RadNet, Inc.
1510 Cotner Avenue
Los Angeles, California 90025
| Phone | 1-310-445-2800 | Revenue | 1.62B | |
| Industry | Medical/Nursing Services | Net Income | 3.04M | |
| Sector | Health Services | 2023 Sales Growth | 13.046% | |
| Fiscal Year-end | 12 / 2024 | Employees | 7,872 | |
| View SEC Filings |
RDNT Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 738.217 |
| Price to Sales Ratio | 1.391 |
| Price to Book Ratio | 3.746 |
| Price to Cash Flow Ratio | 10.179 |
| Enterprise Value to EBITDA | 12.671 |
| Enterprise Value to Sales | 2.214 |
| Total Debt to Enterprise Value | 0.417 |
RDNT Efficiency
| Revenue/Employee | 205,364.583 |
| Income Per Employee | 386.687 |
| Receivables Turnover | 8.551 |
| Total Asset Turnover | 0.584 |
RDNT Liquidity
| Current Ratio | 1.324 |
| Quick Ratio | 1.324 |
| Cash Ratio | 0.783 |
RDNT Profitability
| Gross Margin | 5.753 |
| Operating Margin | 5.753 |
| Pretax Margin | 2.401 |
| Net Margin | 0.188 |
| Return on Assets | 0.11 |
| Return on Equity | 0.632 |
| Return on Total Capital | 0.143 |
| Return on Invested Capital | 0.159 |
RDNT Capital Structure
| Total Debt to Total Equity | 236.425 |
| Total Debt to Total Capital | 70.276 |
| Total Debt to Total Assets | 51.655 |
| Long-Term Debt to Equity | 224.699 |
| Long-Term Debt to Total Capital | 66.79 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Radnet Inc. - RDNT
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.07B | 1.32B | 1.43B | 1.62B | |
Sales Growth
| -7.13% | +22.69% | +8.74% | +13.05% | |
Cost of Goods Sold (COGS) incl D&A
| 1.05B | 1.22B | 1.38B | 1.52B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 154.71M | 170.66M | 184.72M | 189.49M | |
Depreciation
| 151.01M | 166.26M | 174.62M | 177.29M | |
Amortization of Intangibles
| 3.70M | 4.40M | 10.10M | 12.20M | |
COGS Growth
| -2.56% | +15.89% | +13.14% | +10.39% | |
Gross Income
| 19.14M | 95.11M | 49.84M | 93.00M | |
Gross Income Growth
| -74.09% | +396.83% | -47.60% | +86.60% | |
Gross Profit Margin
| +1.79% | +7.23% | +3.49% | +5.75% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| - | - | - | - | - |
Research & Development
| - | - | - | - | - |
Other SG&A
| - | - | - | - | - |
SGA Growth
| - | - | - | - | - |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| (19.26M) | (4.32M) | (37.94M) | 17.11M | |
EBIT after Unusual Expense
| 38.40M | 99.43M | 87.78M | 75.89M | |
Non Operating Income/Expense
| 6.63M | 8.28M | 6.03M | 27.40M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 7.95M | 10.97M | 10.39M | 6.43M | |
Interest Expense
| 45.88M | 48.83M | 50.84M | 64.48M | |
Interest Expense Growth
| -4.50% | +6.43% | +4.12% | +26.83% | |
Gross Interest Expense
| 45.88M | 48.83M | 50.84M | 64.48M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (854.00K) | 58.88M | 42.97M | 38.81M | |
Pretax Income Growth
| -102.88% | +6,994.50% | -27.02% | -9.68% | |
Pretax Margin
| -0.08% | +4.48% | +3.00% | +2.40% | |
Income Tax
| 895.00K | 14.56M | 9.36M | 8.47M | |
Income Tax - Current - Domestic
| (1.86M) | (2.19M) | 371.00K | 3.44M | |
Income Tax - Current - Foreign
| 27.00K | 18.00K | 87.00K | 638.00K | |
Income Tax - Deferred - Domestic
| 2.73M | 16.73M | 12.33M | 6.24M | |
Income Tax - Deferred - Foreign
| - | - | (3.43M) | (1.84M) | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 7.95M | 10.97M | 10.39M | 6.43M | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (1.75M) | 44.32M | 33.61M | 30.34M | |
Minority Interest Expense
| 13.09M | 19.59M | 22.96M | 27.29M | |
Net Income
| (14.84M) | 24.73M | 10.65M | 3.04M | |
Net Income Growth
| -200.57% | +266.62% | -56.93% | -71.42% | |
Net Margin Growth
| -1.38% | +1.88% | +0.74% | +0.19% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (14.84M) | 24.73M | 10.65M | 3.04M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (14.84M) | 24.73M | 10.65M | 3.04M | |
EPS (Basic)
| -0.2916 | 0.471 | 0.1892 | 0.0479 | |
EPS (Basic) Growth
| -198.18% | +261.52% | -59.83% | -74.68% | |
Basic Shares Outstanding
| 50.89M | 52.50M | 56.29M | 63.58M | |
EPS (Diluted)
| -0.2916 | 0.4629 | 0.1732 | 0.0471 | |
EPS (Diluted) Growth
| -199.28% | +258.74% | -62.58% | -72.81% | |
Diluted Shares Outstanding
| 50.89M | 53.42M | 57.32M | 64.66M | |
EBITDA
| 173.85M | 265.77M | 234.56M | 282.49M | |
EBITDA Growth
| -21.45% | +52.87% | -11.74% | +20.43% | |
EBITDA Margin
| +16.22% | +20.21% | +16.40% | +17.47% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 86.833 | |
| Number of Ratings | 6 | Current Quarters Estimate | 0.192 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 0.217 | |
| Last Quarter’s Earnings | 0.04 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.05 | Next Fiscal Year Estimate | 0.606 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 3 | 3 | 3 | 3 |
| Mean Estimate | 0.19 | 0.00 | 0.22 | 0.61 |
| High Estimates | 0.29 | 0.04 | 0.28 | 0.90 |
| Low Estimate | 0.14 | -0.04 | 0.11 | 0.45 |
| Coefficient of Variance | 44.60 | 1,212.57 | 43.07 | 42.13 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 4 |
| OVERWEIGHT | 2 | 2 | 1 |
| HOLD | 0 | 0 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Overweight |
SEC Filings for Radnet Inc. - RDNT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Radnet Inc. - RDNT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Aug 23, 2024 | Michael N. Murdock EVP, Mergers and Acquisitions | 58,953 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $61.91 per share | 3,649,780.23 |
| Aug 23, 2024 | Michael N. Murdock EVP, Mergers and Acquisitions | 49,624 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $63.06 per share | 3,129,289.44 |
| Aug 23, 2024 | Michael N. Murdock EVP, Mergers and Acquisitions | 48,144 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $63.48 per share | 3,056,181.12 |
| Jun 21, 2024 | Mital Patel EVP, Chief Admin Officer | 202,146 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $59 per share | 11,926,614.00 |
| Jun 21, 2024 | Mital Patel EVP, Chief Admin Officer | 231,946 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $60 per share | 13,916,760.00 |
| Jun 19, 2024 | Gregory E. Spurlock Director | 2,591 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $59.75 per share | 154,812.25 |
| Jun 19, 2024 | Gregory E. Spurlock Director | 9,758 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $59.75 per share | 583,040.50 |
| Jun 14, 2024 | A. Gregory Sorensen EVP, Chief Science Officer; Director | 1,249,205 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $61.24 per share | 76,501,314.20 |
| Jun 14, 2024 | A. Gregory Sorensen EVP, Chief Science Officer; Director | 1,239,205 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $62.34 per share | 77,252,039.70 |
| Jun 14, 2024 | Laura P. Jacobs Director | 24,308 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 14, 2024 | Stephen M. Forthuber Pres & COO-Eastern Operations | 523,561 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $62.33 per share | 32,633,557.13 |
| Jun 14, 2024 | Lawrence L. Levitt Director | 176,657 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 14, 2024 | David L. Swartz Director | 199,067 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 13, 2024 | Norman R. Hames Pres and COO-West Operations | 280,919 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $61.15 per share | 17,178,196.85 |
| Jun 13, 2024 | Norman R. Hames Pres and COO-West Operations | 245,919 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $61.4 per share | 15,099,426.60 |
| Jun 13, 2024 | Norman R. Hames Pres and COO-West Operations | 227,322 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $63.08 per share | 14,339,471.76 |
| Jun 13, 2024 | Norman R. Hames Pres and COO-West Operations | 24,889 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $61.09 per share | 1,520,469.01 |
| Jun 13, 2024 | David L. Swartz Director | 196,476 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $62.42 per share | 12,264,031.92 |
| Jun 13, 2024 | Mark D. Stolper EVP, Chief Financial Officer | 80,398 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $61.27 per share | 4,925,985.46 |
| Jun 12, 2024 | Christine N. Gordon Director | 10,879 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $61.03 per share | 663,945.37 |